Monopar Announces Promising Preclinical Data for its
WILMETTE, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on...
Source: globenewswire.com
Actinium News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Actinium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Actinium Today - Breaking & Trending Today
12 Stocks to Play the Future of Healthcare, From Our Roundtable Experts
Weight-loss treatments aren’t the only big deal in medicine. Our 2023 healthcare roundtable explores the best investing opportunities.
Source: marketwatch.com
Lilly enters radiopharma space with $1.4B buyout of Point Biopharma
Indianapolis-based Eli Lilly and Co. agreed to acquire Point Biopharma Global Inc. for $12.50 per share in cash, or about $1.4 billion, in a deal that would bring the pharma company a pipeline of preclinical and clinical radioligand therapies for cancer. The purchase price is an 87% premium to Point’s closing stock price on Oct. 2, and a 68% premium to the 30-day volume-weighted average price. Shares (NASDAQ:PNT) of Point, also of Indianapolis, rose 84.9%, or $5.67, to close at $12.36 on Oct. 3.
Source: bioworld.com
NIT Research: Nano Imrad Technology Announces Availability of Actinium-225, Pioneering a New Era of Cancer Treatment
Beginning in the second quarter of 2023, NIT will provide Actinium-225 in millicurie quantities, marking a significant step forward in cancer treatmentDALLAS, TX / ACCESSWIRE / June 15, 2023 / Nano Imrad
Source: finanznachrichten.de
Actinium Pharmaceuticals: Actinium Announces Positive Phase 3 Trial Results, NCI CRADA For AML Drug Candidates - Could They Become New Standards Of Care For This Deadly Disease?
NEW YORK, NY / ACCESSWIRE / April 21, 2023 / Patients with relapsed or refractory (r/r) acute myeloid leukemia (AML) have a poor prognosis, and treatment remains challenging. It is a devastating disease
Source: finanznachrichten.de